Bal Pharma Limited - Asset Resilience Ratio

Latest as of March 2026: 0.55%

Bal Pharma Limited (BALPHARMA) has an Asset Resilience Ratio of 0.55% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See BALPHARMA working capital efficiency to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

Rs20.82 Million

≈ $225.13K USD Cash + Short-term Investments

Total Assets

Rs3.76 Billion

≈ $40.61 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2006–2026)

This chart shows how Bal Pharma Limited's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see BALPHARMA total assets.

Liquid Assets Composition Over Time

This chart breaks down Bal Pharma Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore long-term investment intensity of Bal Pharma Limited to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Rs0.00	0%
Short-term Investments	Rs20.82 Million	0.55%
Total Liquid Assets	Rs20.82 Million	0.55%

Asset Resilience Insights

Limited Liquidity: Bal Pharma Limited maintains only 0.55% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Bal Pharma Limited Industry Peers by Asset Resilience Ratio

Compare Bal Pharma Limited's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Kamada TA:KMDA	Drug Manufacturers - Specialty & Generic	0.00%
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Viatris Inc NASDAQ:VTRS	Drug Manufacturers - Specialty & Generic	1.48%
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Shijiazhuang Yiling Pharmaceutical Co Ltd SHE:002603	Drug Manufacturers - Specialty & Generic	11.60%
Chengdu Kanghong Pharmaceuticals Group Co Ltd SHE:002773	Drug Manufacturers - Specialty & Generic	4.31%
Yipinhong Pharmaceutical Co Ltd Class A SHE:300723	Drug Manufacturers - Specialty & Generic	1.01%
Avadel Pharmaceuticals PLC NASDAQ:AVDL	Drug Manufacturers - Specialty & Generic	5.90%

Annual Asset Resilience Ratio for Bal Pharma Limited (2006–2026)

The table below shows the annual Asset Resilience Ratio data for Bal Pharma Limited.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2026-03-31	0.55%	Rs20.82 Million ≈ $225.13K	Rs3.76 Billion ≈ $40.61 Million	-4.42pp
2025-03-31	4.98%	Rs167.09 Million ≈ $1.81 Million	Rs3.36 Billion ≈ $36.30 Million	-4.11pp
2024-03-31	9.08%	Rs290.26 Million ≈ $3.14 Million	Rs3.20 Billion ≈ $34.56 Million	+6.70pp
2023-03-31	2.38%	Rs74.63 Million ≈ $807.07K	Rs3.13 Billion ≈ $33.87 Million	+0.38pp
2022-03-31	2.00%	Rs52.20 Million ≈ $564.58K	Rs2.61 Billion ≈ $28.18 Million	+0.35pp
2021-03-31	1.65%	Rs39.71 Million ≈ $429.44K	Rs2.40 Billion ≈ $25.96 Million	+0.18pp
2020-03-31	1.47%	Rs35.07 Million ≈ $379.23K	Rs2.38 Billion ≈ $25.78 Million	-0.12pp
2019-03-31	1.59%	Rs41.46 Million ≈ $448.35K	Rs2.61 Billion ≈ $28.26 Million	-0.02pp
2018-03-31	1.60%	Rs40.40 Million ≈ $436.86K	Rs2.52 Billion ≈ $27.23 Million	-0.40pp
2017-03-31	2.01%	Rs46.21 Million ≈ $499.73K	Rs2.30 Billion ≈ $24.90 Million	+2.16pp
2016-03-31	-0.15%	Rs-3.19 Million ≈ $-34.54K	Rs2.11 Billion ≈ $22.82 Million	+0.03pp
2015-03-31	-0.18%	Rs-2.93 Million ≈ $-31.72K	Rs1.64 Billion ≈ $17.72 Million	-0.18pp
2014-03-31	0.00%	Rs-22.18K ≈ $-239.89	Rs1.55 Billion ≈ $16.73 Million	+0.04pp
2013-03-31	-0.04%	Rs-574.01K ≈ $-6.21K	Rs1.50 Billion ≈ $16.20 Million	-0.04pp
2007-03-31	0.00%	Rs13.72K ≈ $148.43	Rs905.28 Million ≈ $9.79 Million	0.00pp
2006-03-31	0.00%	Rs13.72K ≈ $148.43	Rs881.03 Million ≈ $9.53 Million	--

pp = percentage points

About Bal Pharma Limited

NSE:BALPHARMA India Drug Manufacturers - Specialty & Generic

Market Cap

$17.64 Million

Rs1.63 Billion INR

Market Cap Rank

#25596 Global

#1411 in India

Share Price

Rs102.46

Change (1 day)

-4.64%

52-Week Range

Rs60.42 - Rs114.45

All Time High

Rs151.23